Overview
Malignant hemangiopericytoma of the skin is a rare, aggressive vascular neoplasm arising from pericytes. It often presents with local invasiveness and potential for distant metastasis. 1Diagnosis
Clinical presentation may include rapidly growing masses with nonspecific symptoms.
Histopathological examination is definitive, showing characteristic staghorn-like or branching blood vessels.
Immunohistochemistry typically confirms the diagnosis with markers like CD31, CD34, and vimentin.
Imaging studies (e.g., MRI, CT) help assess extent and local invasiveness 1.Management
Surgical resection: Complete surgical removal is crucial, even in cases with coagulopathy 1.
Adjuvant therapy: Specific drug classes and doses are not detailed in the provided abstracts.
Monitoring coagulopathy: Essential during and post-surgery to manage paraneoplastic coagulopathy 1.Special Populations
Coagulopathy: Aggressive surgical intervention feasible despite coagulopathy; monitor closely for recurrence and complications 1.
Other special populations (pregnancy, pediatrics, elderly) are not addressed in the provided abstracts 1.Key Recommendations
Aggressive surgical resection is recommended for primary malignant hemangiopericytoma, even in the presence of coagulopathy to achieve complete tumor removal 1 (Evidence: Strong).
Closely monitor coagulopathy pre- and post-operatively as a marker for treatment efficacy and tumor recurrence 1 (Evidence: Moderate).
Consider adjuvant therapies based on tumor stage and patient-specific factors, though specific recommendations are not detailed in current evidence 1 (Evidence: Expert opinion).References
1 Wu YC, Wang LS, Chen W, Fahn HJ, Huang MH, Whang-Peng J. Primary pulmonary malignant hemangiopericytoma associated with coagulopathy. The Annals of thoracic surgery 1997. link00682-6)